The LSTM in the UK has opened a £20m ($23.2m) robotic AI laboratory to test drugs and vaccines against infections and diseases.

The EAHP and EFPIA want all individual doses to carry a barcode, an addition they say will further reduce medication errors.

Credit: Jo Panuwat D/Shutterstock.com Drug delivery specialist Aptar Pharma is collaborating with Aceso Therapeutics to advance development for the latter’s ACT-101 – an inhalable antisense ...

The FDA has granted accelerated approval to AstraZeneca's Etcamah (camizestrant), used with a CDK 4/6 inhibitor, for breast cancer.

The identification of breeding Aedes aegypti in the UK follows the establishment of an invasive mosquito population in a region of Cyprus.

The FDA's latest efforts to curb the illicit US medicines trade are primarily centred around weight loss and fat-reducing peptides.

Ionis claims Zanvastro will become available to US patients with rare neurodegenerative condition, Alexander disease “in the coming weeks”.

The FDA has so far approved four botanical products, with a view to greenlight more. Credit: Svetliy/Shutterstock.com. The US Food and Drug Administration (FDA) is requesting public input on both the ...

Novartis has signed an agreement with Alteogen that could be worth up to $3.22bn for the development and commercialisation of subcutaneous drug formulations using Alteogen’s ALT-B4 technology.

Typewriter harnesses a non-viral approach as viral vectors increasingly come under the spotlight for their associated safety risks.

At ESC 2026, a session presented by Dr Domenica Rubino covered the considerations to take into account when comparing oral and injectable formulations of GLP-1 therapies.

Novartis India’s board cleared the deal, after which the company signed an asset purchase agreement with Pfizer entities. Credit: JHVEPhoto / Shutterstock.com. Novartis India has agreed to pay ...